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Abstract
Background: The importance of evaluating the outcomes of health care from the standpoint of the patient is
now widely recognized. The purpose of this study is to develop and test a Japanese version of the National Eye
Institute Visual Function Questionnaire (NEI VFQ-25).
Methods: A Japanese version was developed with a previously standardized method. The questionnaire and
optional items were completed by 245 patients with cataracts, glaucoma, or age-related macular degeneration, by
110 others before and after cataract surgery, and by a reference group (n = 31). We computed rates of missing
data, measured reproducibility and internal consistency reliability, and tested for convergent and discriminant
validity, concurrent validity, known-groups validity, factor structure, and responsiveness to change.
Results: Based on information from the participants, some items were changed to 2-step items (asking if an
activity was done, and if it was done, then asking how difficult it was). The near-vision and distance-vision subscales
each had 1 item that was endorsed by very few participants, so these items were replaced with items that were
optional in the English version. For example, more than 60% of participants did not drive, so the driving question
was excluded. Reliability and validity were adequate for all subscales except driving, ocular pain, color vision, and
peripheral vision. With cataract surgery, most scores improved by at least 20 points.
Conclusion: With minor modifications from the English version, the Japanese NEI VFQ-25 can give reliable, valid,
responsive data on vision-related quality of life, for group-level comparisons or for tracking therapeutic outcomes.
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Background
The importance of evaluating the outcomes of health care
from the standpoint of the patient is now widely recog-
nized. Measures of health-related quality of life (HRQOL)
have been used to track outcomes for many eye diseases
[1-6]. HRQOL refers to health status in the physical, men-
tal, and social domains, and to the effect of a disease, its
symptoms, and treatments on patients' lives. Conven-
tional clinical measures such as visual acuity and visual
field assessments do not fully capture the influence of vis-
ual disability on daily visual functioning and on abilities
to perform activities of daily living that are valued by
patients.
In response to a need for a vision-targeted measure of
quality of life, the National Eye Institute (NEI) funded the
development of such an instrument in the mid-1990s.
The resulting 51-item questionnaire is known as the
National Eye Institute Visual Function Questionnaire
(NEI VFQ) [7,8]. To lessen the burden on respondents
and to improve data quality, a shorter version was devel-
oped: the NEI VFQ-25 [9]. The NEI VFQ-25 has 25 items
that measure vision-targeted HRQOL and are grouped
into 12 subscales: general health (GH, 1 item); general
vision (GV, 1 item); ocular pain (OP, 2 items); difficulty
with near-vision activities (NV, 3 items); difficulty with
distance-vision activities (DV 3 items); limitation of social
functioning due to vision (SF, 2 items); mental health
problems due to vision (MH, 4 items), role limitations
due to vision (RL, 2 items); dependency on others due to
vision (DP, 3 items); driving difficulties (DR, 2 items); dif-
ficulty with color vision (CV, 1 item); and difficulty with
peripheral vision (PV, 1 item). Each subscale score is con-
verted to a score between 0 and 100, and higher scores
indicate better vision-specific HRQOL. The composite
VFQ-25 score is the mean score of all items except for the
general health item. The VFQ-25 has adequate reliability
and validity, and subscale scores from the shorter form
correlate highly with scores on the original long version.
This questionnaire has been translated into Italian,
French, Spanish, and German, and validated [10-13], and
it has been widely used to describe the HRQOL of patients
with ocular disease and to assess the treatment of ocular
disease [14-20].
We developed a Japanese version of the NEI VFQ-25
(Appendix [see additional file 1]). and evaluated its psy-
chometric characteristics. We investigated three points in
particular. First, we looked at each question item in the
Japanese version quantitatively and qualitatively, taking
into consideration Japanese lifestyles, and made the nec-
essary adaptations. Second, although composite NEI
VFQ-25 scores can be computed, there is no published
evidence of this scale's uni-dimensionality. Therefore, on
the basis of the Japanese version's factor structure and
other psychometric characteristics, we propose a particu-
lar combination of subscales that can be used to compute
an appropriate composite score. Third, research on the
responsiveness of the NEI VFQ-25 is limited [4,21], so we
quantified its responsiveness, using data obtained before
and after cataract surgery.
Methods
Development of the Japanese version
One of us (CMM) was a developer of the original NEI
VFQ-25. The Japanese version was developed in conform-
ance with standard methods that have been adopted inter-
nationally [22], including forward translation, back-
translation, examination of the translation quality and
adjudication by bilingual speakers, and a pilot test on 15
persons. One item was changed to make then more
appropriate to Japanese life style and culture (details
below). The content of the translated questionnaire was
reviewed by one of the original developers of the English
version, and the Japanese version was considered appro-
priate for administration in a psychometric field test.
Study design and population
Two groups of patients were studied. The first group was a
convenience sample of 276 outpatients who visited the
departments of ophthalmology at 5 hospitals. To partici-
pate, patients had to be 21 years of age or older, had to
have clinical evidence of age-related cataracts, glaucoma,
or age-related macular degeneration (ARMD), and had to
have been seen at least twice in the past 3 months at the
participating hospital. For patients with cataracts, the
inclusion criteria were having cataracts in both eyes and
20/30 or worse visual acuity in the better eye. Inclusion
criteria for patients with glaucoma were binocular pri-
mary open-angle glaucoma, binocular abnormalities as
measured with a Humphrey field analyzer, defects in the
optic nerve, at least one documented instance (in each
eye) of intraocular pressure greater than 21 mmHg, and
no incisional surgery for treatment of glaucoma during
the previous 3 months. For patients with ARMD, there
were three inclusion criteria: having at least one of the fol-
lowing 5 conditions: abnormal retinal pigmented epithe-
lium, sub-retinal neovascular membrane, disciform scar,
previous laser treatment to the macula, or geographic
atrophy involving the fovea; having small drusen in other
areas; and binocular involvement. Also included in Sam-
ple 1 was a reference group of patients with refractive error
only and hospital employees.
The second sample consisted of 110 patients who had
been recruited from 6 different departments of ophthal-
mology and were scheduled for bilateral cataract surgery
(phacoemulsification and implantation of foldable
intraocular lenses). Inclusion criteria for these patientsHealth and Quality of Life Outcomes 2005, 3:65 http://www.hqlo.com/content/3/1/65
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were bilateral cataracts and preoperative corrected visual
acuity of 20/30 or better in both eyes.
Attending physicians explained the research and ethical
considerations to the participants, who then indicated
their understanding by signing an informed-consent
form. This study was done in accord with the Declaration
of Helsinki.
Data collection
All surveys were administered by a trained interviewer.
The interviewers had no direct involvement in the medical
care of the patients. The interviews included the Japanese
version of the NEI VFQ-25 and 14 optional items about
aspects of vision-specific HRQOL (which were not pre-
sented to patients who underwent cataract surgery), and
SF-36 to measure general HRQOL [23,24].
The attending physician recorded, on a structured form,
the type of eye disease, duration of disease, uncorrected
vision, maximally refracted vision, vision with habitual
correction, and ocular pressure. In addition, severity of
age-related cataracts was graded with the Lens Opacities
Classification System (LOCS) III (slit lamp, standard test-
ing conditions [25]), and in participants with glaucoma
visual field was assessed with a Humphrey field analyzer
30-2. In patients with ARMD, the type of ARMD and the
size and location of absolute scotoma were recorded. The
data were managed by ID number, and were analyzed in
a way that maintained the participants' privacy.
Statistical analysis
All statistical analyses were done with SPSS version 12 for
Windows (SPSS Inc, Chicago, IL).
Descriptive analysis and item analysis
The item analysis was done using the data from the multi-
condition group (Sample 1). The percentage of missing
values was examined for each item. We also examined
whether each item's distribution of responses was strongly
skewed (large ceiling effect or floor effect).
Reliability
Cross-sectional data from the multi-condition group
(Sample 1) were used to quantify reliability. Cronbach's
alpha coefficient [26] was used as the index of internal
consistency for each subscale. To quantify test-retest relia-
bility, intraclass correlation coefficients [27] were used.
The test-retest data were obtained from clinically stable
patients with age-related cataracts, in surveys done 2
weeks apart.
Validity
The use of multi-trait analysis to evaluate convergent and
discriminant validity has been described previously in
detail [28]. What follows is a brief summary of the
method: Each item is hypothesized to belong to only one
multi-item subscale. For each item, correlations between
the score on that item and the scores on all the subscales
are computed. Then, for each item, if the correlation
between the score on that item and the score on the sub-
scale to which that item belongs is 0.4 or higher, that item
is said to have "passed" the test of convergent validity.
Also for each item, if the correlation between the score on
that item and the score on the subscale to which that item
belongs is greater than the correlations between the score
on that item and the scores on all the subscales to which
it that item does not belong, then that item is said to have
"passed" the test of discriminant validity [29].
To assess concurrent validity, we computed correlations
between scores on the NEI VFQ-25 and on the SF-36 sub-
scales. We hypothesized that the NEI VFQ-25 "mental
health", "social functioning", "role difficulties" and
"dependency" scores would be associated more strongly
with the SF-36 subscale scores that measured similar
domains.
The subscale scores of participants with poor visual acuity
were compared to those of participants with better visual
acuity. Also, by analysis of variance, the subscale scores
were compared among those with age-related cataracts,
ARMD, and the reference group. In addition, scores on the
peripheral-vision subscale in the patients with glaucoma
were compared to those in the reference group. We also
computed the correlations between subscale scores and
visual acuity with habitual correction in the better and
worse eye and deficits in visual fields as measured by the
Humphrey Field Analyzer 30-2 in the better and worse
eye.
Finally, we used factor analysis to assess the uni-dimen-
sionality of the scale, in preparation for computing a com-
posite score. Factor analysis was done using 10 subscales
('General Health' and 'Driving' were not included), with
the maximum-likelihood solution and promax rotation.
The 'Driving' subscale was not included because more
than 60% of the responses on this subscale were missing.
Responsiveness
Responsiveness was studied using data from the reference
group and from the patients who completed the survey
before and 2 months after cataract surgery. Differences
related to cataract surgery were analyzed with Student's t-
test for paired data, and with the responsiveness statistic
of Guyatt [30]. The responsiveness statistic is the ratio of
the clinically important difference (sometimes denoted
by the Greek letter delta in sample-size calculations) to
the variability in stable subjects (the square root of twice
the mean square error).Health and Quality of Life Outcomes 2005, 3:65 http://www.hqlo.com/content/3/1/65
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Results
Translation and pilot test
On the basis of the translations and discussions among
the developers, one item was changed to conform better
to Japanese norms. In The item "Because of your eyesight,
how much difficulty do you have visiting with people in
their homes, at parties, or in restaurants?", "visit at par-
ties" was changed to "going to gatherings". Also, when a
pilot test was done in 5 subjects without eye disease and
10 subjects with eye conditions, we found no expression
equivalent to 'not applicable'. Therefore each item was
rewritten so that it had a stem, in which the participants
were asked whether they did the activity. If they indicated
that they did the activity, then they were asked about the
degree of difficulty in doing it. If they indicated that they
did not do the activity, then they were asked whether this
was due to vision problems. All such changes were dis-
cussed with, and approved by, one of the original NEI
VFQ developers (CMM).
Subjects
Sample 1 had 276 participants and Sample 2 had 110. All
those in Sample 1 were included in the analytic sample. In
Sample 2, 4 patients did not answer the questionnaire and
11 did not respond after cataract surgery, thus 95 patients
were in the analytic sample for this group. The character-
istics of the participants are shown in Table 1.
Of the patients with ARMD, 7 had only dry change in both
eye, 8 had exudative changes in one eye, 56 patients had
exudative changes in both eyes, and the status 9 patients
was unknown. In the patients with glaucoma, their mean
dB threshold values were -12.8 for the right eye and -12.9
for the left eye with Humphrey 30-2 threshold perimetry
test. In the cataract patients of sample 1, the mean values
measured by LOCS III were 2.04 for nuclear color, 2.07 for
nuclear opalescence, 2.42 for cortical opacity, and 1.84 for
posterior subcapsular opacity in better eye. The mean val-
ues in sample-2 patients were 2.76, 2.78, 3.31 and 2.18
respectively.
Item analysis
Percentages of missing values for each item and propor-
tions of responses at the floor (the lowest possible score)
and ceiling (the highest possible score) are shown in Table
2. 'Finding objects on crowded shelf' which was included
in the 'Near Vision' subscale was not endorsed by 28% of
the respondents, while 'going out to movies/plays' which
was included in the 'Distance Vision' subscale was not
endorsed by 32% of the sample. Three items each from
the 'Near Vision' and 'Distance Vision' subscales in the
optional item pool were included in the questionnaire
(NV: reading small print, reading mail/bills, shaving/styl-
ing hair, DV: recognizing faces in room, participating in
sports, seeing television). Subsequently, items with low
rates of missing data were substituted for those with high
rates, as long as the percentage of responses at the ceiling
or floor did not exceed 50%. The result was that 'reading
small print' was selected for the 'Near Vision' subscale and
'seeing television program' was selected for the 'Distance
Vision' subscale.
More than 60% of the answers were missing for the 'Driv-
ing' subscale, which was much higher than the 16% and
31% obtained from surveys done in the United States.
Reliability
Cronbach's alpha (the index of internal consistency relia-
bility) was 0.7 or higher for almost all of the subscales. It
was lower for the 'Ocular Pain' and 'Driving' subscales.
With regard to test-retest reliability, the intraclass correla-
tion coefficient was 0.7 or higher for all of the subscales
Table 1: Sociodemographic and clinical characteristics of the two samples
Sample 1, n = 276 Sample 2, n = 95
Mean of age (range) 66.8 (21 to 95) 71.9 (52 to 86)
Female (%) 141 (51.0) 71 (74.7)
Visual acuity (Snellen fraction)
Better eye, mean (range) 20/120 (20/13 to 20/2000) 20/110 (20/16 to 20/2000)
Worse eye, mean (range) 20/200 (20/13 to 20/2000) 20/200 (20/20 to 20/2000)
Chronic eye disease, number (%)
Age-related cataract 96 (34.8) 95 (100)
Glaucoma 69 (25.0) Not applicable
Age-related macular degeneration 80 (29.0) Not applicable
Normal reference 31 (11.2) Not applicable
Medical comorbidities*
0 104 (37.7) Not applicable
1 97 (35.1) Not applicable
2 or more 75 (27.2) Not applicableHealth and Quality of Life Outcomes 2005, 3:65 http://www.hqlo.com/content/3/1/65
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except 'General Health', 'General Vision', and 'Peripheral
Vision' (Table 3). These values are considered to indicate
adequate reliability for group-level comparisons [31].
Substitution of items in the 'Near Vision' and 'Distance
Vision' subscales (described above) did not affect the reli-
ability of those subscales.
Validity
All items passed the test of convergent validity, and 80%
passed the test of discriminant validity. The success rates
for the 'Near Vision' and 'Distance Vision' subscales were
higher after item substitution than before (Table 3).
For concurrent validity, there were high correlations
between scores on the NEI VFQ-25 subscales and similar
Table 2: Results of item analysis. Number and percentage of missing data and of responses at the floor and ceiling (n = 276)
Subscale and Item Missing Number (%) Floor Number (%) Ceiling Number (%)
General health: GH
5-level health rating 1 (<1) 11 (4) 7 (3)
General vision: GV
5-level general vision 2 (<1) 6 (2) 1 (<1)
Near vision: NV
Reading normal newsprint 16 (6) 49 (18) 38 (14)
See well up close 36 (13) 43 (16) 43 (16)
Finding objects on crowded shelf 78 (28) 31 (11) 47 (17)
Distance vision: DV
Going out to movies/plays 88 (32) 72 (26) 37 (13)
Going down stairs at night 24 (9) 38 (14) 36 (13)
Reading street signs 11 (4) 27 (10) 53 (19)
Driving: DR
Daylight familiar places 169 (61) 43 (16) 39 (14)
Driving at night 221 (80) 15 (5) 7 (3)
Peripheral vision: PV
Seeing objects off to side 6 (2) 8 (3) 47 (17)
Color vision: CV
Difficulty matching clothes 27 (10) 5 (2) 158 (57)
Ocular pain: OP
Amount pain 1 (<1) 2 (<1) 122 (44)
Amount time: pain 0 7 (3) 189 (69)
Role limitations: RL
Accomplish less 1 (<1) 31 (11) 85 (31)
Limited in endurance 3 (1) 29 (11) 105 (38)
Dependency: DP
Need much help from others 0 32 (12) 143 (52)
Stay home most of time 1 (<1) 38 (14) 127 (46)
Rely too much on other's word 0 29 (11) 154 (56)
Social function: SF
Seeing how people react 40 (14) 22 (8) 64 (23)
Visiting others 25 (9) 22 (8) 98 (36)
Mental health: MH
Amount true: frustrated 1 (<1) 30 (11) 117 (42)
Amount true: embarrassment 1 (<1) 31 (11) 134 (49)
Amount true: no control 2 (<1) 57 (21) 86 (31)
Amount true: worry 1 (<1) 40 (15) 32 (12)
Optional items
Near vision: NV
Reading small print 6 (2) 53 (19) 36 (13)
Reading mail/bills accurately 34 (12) 41 (15) 48 (17)
Shaving/styling hair/makeup 3 (1) 3 (1) 150 (54)
Distance vision: DV
Recognizing faces in room 19 (7) 25 (9) 78 (28)
Participating in sports/outdoors 105 (38) 41 (15) 62 (23)
Seeing television program 5 (2) 17 (6) 91 (33)Health and Quality of Life Outcomes 2005, 3:65 http://www.hqlo.com/content/3/1/65
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domains of the SF-36 (Table 4). For example, The highest
correlations were with the "Vitality" and "Mental Health"
subscales, followed by the "Role Physical" and "Role
Emotional" subscales. Correlations with the "Bodily
Pain" and "Physical Functioning" subscales were low.
The mean scores and the standard errors after adjustment
for sex, age, and number of comorbid conditions are
shown in Table 5. All scores were lower for those patients
with age-related cataracts than for those in the reference
group, with the exception of the 'Peripheral Vision', 'Color
Table 3: Internal consistency and test-retest reliability of NEI VFQ-25 subscales
Number of 
items
Cronbach's 
alpha
Intraclass 
correlation, for 
test-retest 
reliability
Range of item-scale 
correlations
Convergent 
validity*
Discriminant 
validity**
General health 1 NA*** 0.51 NA NA NA
General vision 1 NA 0.48 NA NA NA
Near vision**** 3 0.87 (0.85) 0.76 (0.69) 0.65 – 0.75 (0.69 – 0.73) 100 (100) 93.9 (100)
Distance vision**** 3 0.84 (0.79) 0.85 (0.69) 0.67 – 0.75 (0.57 – 0.69) 100 (100) 90.9 (100)
Driving 2 0.58 0.99 0.49 – 0.49 100 50.0
Peripheral vision 1 NA 0.62 NA NA NA
Color vision 1 NA 0.74 NA NA NA
Ocular pain 2 0.44 0.75 0.28 – 0.28 0 81.8
Vision-specific
Role limitation 2 0.82 0.88 0.70 – 0.70 100 90.9
Dependency 3 0.87 0.90 0.71 – 0.82 100 97.0
Social function 2 0.74 0.88 0.58 – 0.58 100 59.1
Mental health 4 0.84 0.94 0.62 – 0.75 100 90.9
25-item composite 25 0.96 0.94 NA NA NA
* The percentage of items that passed the test of convergent validity (as described in the text).
** The percentage of items that passed the test of discriminant validity (as described in the text).
*** NA: Not applicable to single-item scales
**** Scores were recomputed after the substitution of items described in the text. Results of the recomputations are in parentheses.
Table 6: Pearson correlations of NEI VFQ-25 subscale scores with visual acuity and visual field
Subscale Visual acuity* Visual field**
Better eye Worse eye Better eye Worse eye
General health 0.06 0.06 0.03 -0.01
General vision 0.55 0.50 0.33 0.39
Near vision*** 0.60 (0.64) 0.56 (0.59) 0.33 (0.34) 0.27 (0.30)
Distance vision*** 0.60 (0.59) 0.51 (0.52) 0.60 (0.54) 0.52 (0.41)
Driving 0.58 0.56 0.61 0.44
Peripheral vision 0.06 0.06 0.45 0.41
Color vision 0.28 0.23 0.01 -0.06
Ocular pain -0.02 -0.02 -0.15 -0.20
Vision-specific
Role limitation 0.51 0.46 0.36 0.19
Dependency 0.59 0.51 0.49 0.40
Social function 0.56 0.47 0.47 0.28
Mental health 0.55 0.49 0.49 0.41
25-item composite 0.61 0.54 0.49 0.39
Bold characters indicate correlation coefficients of 0.4 or greater.
* Visual acuity (logMAR) while wearing usual correction, in all subjects in Sample 1
** Visual field testing with the Humphrey Field Analyzer 30-2 (only glaucoma, n = 69)
*** Scores were recomputed after the substitution of items described in the text. Results of the recomputations are in parentheses.Health and Quality of Life Outcomes 2005, 3:65 http://www.hqlo.com/content/3/1/65
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Vision', 'Ocular Pain', and 'Dependency' subscales. In
addition, the subscales scores were significantly lower for
those with ARMD than for those in the reference group,
with the exception of the 'Peripheral Vision', 'Color
Vision', and 'Ocular Pain' subscales. The item substitution
described above resulted in slightly lower scores on the
Table 4: Correlation of NEI-VFQ 25 subscales and the SF-36
SF-36
Physical 
Functioning
Role Physical Bodily Pain General 
Health
Vitality Social 
Functioning
Role 
Emotional
Mental Health
General health .308 .220 .305 .658 .473 .234 .233 .310
General vision .225 .266 .125 .164 .176 .116 .200 .231
Near vision* .327 .404 .089 .123 .158 .294 .307 .299
Distance vision* .392 .423 .145 .160 .183 .306 .344 .325
Driving .448 .398 .186 .135 .019 .278 .285 .115
Peripheral vision .195 .363 .279 .184 .253 .236 .238 .265
Color vision .412 .313 .145 .207 .141 .297 .296 .204
Ocular pain .276 .279 .306 .249 .269 .321 .266 .377
Vision-specific
Role limitation .340 .418 .173 .200 .200 .292 .376 .332
Dependency .430 .447 .145 .179 .220 .383 .403 .390
Social function .362 .405 .123 .118 .145 .313 .359 .294
Mental health .346 .453 .192 .268 .235 .392 .382 .416
25-item composite .448 .519 .222 .240 .264 .410 .441 .432
*Scores were recomputed after the substitution of items described in the text. Results of the recomputations are in parentheses.
Table 5: NEI VFQ-25 subscale scores and composite score, by condition* and the comparison of R2 between medical condition model 
and visual acuity model
R2 ****
Subscales Cataract n = 96 Glaucoma n = 69 Age-related Macular 
Degeneration n = 78
Reference group 
n = 31
medical condition 
model
visual acuity 
model
General health 46.9 ± 2.0** 43.6 ± 2.3** 45.7 ± 2.4** 59.6 ± 4.4 .198 .209
General vision 56.0 ± 2.0** 62.7 ± 2.3** 41.2 ± 2.4** 74.0 ± 4.5 .273 .269
Near vision*** 63.0 ± 2.6** 
(59.5 ± 5.4**)
69.5 ± 3.0 
(67.9 ± 2.8)
38.6 ± 3.1** 
(31.9 ± 2.9**)
77.4 ± 5.8 
(74.5 ± 5.4)
.341 .346
Distance vision*** 59.1 ± 2.7** 
(65.1 ± 2.3**)
63.3 ± 3.1 
(71.0 ± 2.7**)
40.0 ± 3.2** 
(47.4 ± 2.8**)
75.9 ± 6.0 
(83.7 ± 5.1)
.268 .325
Driving 52.2 ± 5.5** 55.3 ± 6.0** 12.8 ± 5.2** 85.0 ± 10.9 .495 .424
Peripheral vision 57.3 ± 2.7 56.9 ± 3.1 64.1 ± 3.3 69.0 ± 6.1 .029 .126
Color vision 85.2 ± 2.1 89.6 ± 2.4 90.0 ± 2.6 88.1 ± 4.5 .081 .119
Ocular pain 80.5 ± 2.0 81.5 ± 2.4 83.2 ± 2.5 83.3 ± 4.6 .036 .100
Vision-specific
Role limitation 71.3 ± 2.6** 73.5 ± 3.1 38.4 ± 3.2** 85.5 ± 5.9 .340 .252
Dependency 75.6 ± 2.8 83.9 ± 3.3 51.3 ± 3.5** 85.8 ± 6.3 .300 .306
Social function 73.5 ± 2.6** 80.0 ± 2.9 56.3 ± 3.1** 88.1 ± 5.6 .227 .252
Mental health 65.5 ± 2.5** 68.8 ± 2.9** 37.1 ± 3.1** 89.8 ± 5.7 .330 .300
25-item composite 66.0 ± 1.6** 69.8 ± 1.9** 51.0 ± 2.0** 80.1 ± 3.7 .331 .331
* Data are presented as mean ± SE adjusted by sex, age, and number of comorbid conditions.
** Significantly different from the reference group. 
*** Scores were recomputed after the substitution of items described in the text. Results of the recomputations are in parentheses. 
**** R2 showed the comparison of the explanation of variance caused by the influence of medical condition and visual acuity. The medical condition 
model have 'medical condition', 'sex', 'age', and 'number of comorbid condisions' as the explanatory variables and the visual acuity model have 'visual 
acuity', 'sex', 'age', and 'number of comorbid condisions'.Health and Quality of Life Outcomes 2005, 3:65 http://www.hqlo.com/content/3/1/65
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'Near Vision' subscale and slightly higher scores on the
'Distance Vision' subscale. We tried the comparison of the
explanation of variance caused by the influence of medi-
cal condition and visual acuity (Table 5). Two models
associated with the NEI-VFQ score similarly.
Visual acuity in the better eye (logMAR, the logarithm of
the minimum angle of resolution) was strongly correlated
with subscales that are influenced by the ability to use cen-
tral vision: 'General vision', 'Near Vision', and 'Distance
Vision' (Table 6). As would be expected, the logMAR was
only weakly correlated with the subscales that are less
dependent on the quality of central vision: 'General
Health', 'Peripheral vision', 'Ocular Pain', and 'Color
Vision'. In patients with glaucoma, visual field deficits
were strongly correlated with scores on three subscales:
'Distance Vision', 'Driving', and 'Peripheral Vision' (Table
6). These correlations are similar to those observed
between clinical measures and NEI VFQ scores in the NEI
psychometric field test [9].
The results of factor analysis done with 10 subscales
('General Health' and 'Driving' were excluded) are shown
in Table 7. Two factors were extracted. The 'Peripheral
Vision', 'Ocular Pain', and 'Color Vision' subscales were
included in the second factor. The correlation between the
two factors was 0.47. The results of factor analysis done
with 22 items (1 item on 'General Health' and 2 items on
'Driving' were excluded) had the similar to the structure of
scale-level analysis.
Responsiveness
The mean of visual acuity of patients with cataract were
20/200 before surgery, and after surgery it had improved
to 20/50 in the better eye. In the reference group, scores
were stable over two months. In the cataract surgery
group, surgery was associated with significant increases in
the composite score and in 8 subscale scores: 'General
Vision', 'Near Vision', 'Distance Vision', 'Ocular Pain',
'Social Functioning', 'Mental Health', 'Role Limitation',
and 'Dependency' (Figure 1). Guyatt's index of respon-
siveness for those subscale scores ranged from 1.91 to
7.35. Even the lower limit of that range would be consid-
ered to be extremely high [32]. The only exception was the
'General Health' subscale, which would not have been
expected to be strongly influenced by cataract surgery.
On the basis of the result of factor analysis, we computed
3 different composite scores: composite 11 (all VFQ-25
subscales except 'General Health'), composite 10 (all
VFQ-25 subscales except 'General Health' and 'Driving'),
and composite 7 (only those 7 subscales of the VFQ-25
that loaded heavily on Factor 1, as indicated in Table 7).
The responsiveness indexes of these three composite
scores were 7.18, 8.03, and 8.86, respectively, all of which
are acceptable from a psychometric perspective.
Discussion
We developed a Japanese version of the NEI VFQ-25, and
documented its psychometric characteristics in patients
with various chronic eye conditions. Overall, we found
that the Japanese version can provide data that are relia-
ble, valid, and responsive to change in visual function.
In developing the Japanese version, a few changes to the
content of the questionnaire were needed. For some of the
items in the 'Near Vision' and 'Distance Vision' subscales,
we found that the rates of missing data in the Japanese ver-
sion were much higher than in the original English ver-
sion. To minimize the rates of missing data and thereby to
increase the measurement precision, we propose substi-
tuting items that are appropriate for patients in Japan.
Specifically, instead of 'finding objects on crowded shelf',
'reading small print' can be used in the 'Near vision' sub-
scale; and instead of 'going out to movies/plays', 'seeing
television program' can be used in the 'Distance vision'
subscale (both are from the pool of optional NEI VFQ
items). Rates of missing data were much lower after those
substitutions than before. The 'Near Vision' score was
slightly higher and the 'Distance Vision' score was slightly
lower, but their reliability and validity were virtually
unchanged.
The 'Driving' subscale also had a high rate of missing data.
We suggest that in Japan the 'Driving' subscale should be
optional.
Composite scores can be useful summaries of visual func-
tion, particularly when the content of such a score is based
on the results of factor analysis. In this study, factor anal-
ysis indicted that most of the subscales that are influenced
by central vision correlated strongly with the first factor,
Table 7: Results of factor analysis on 10 subscales of VFQ-25 
('General Health' and 'Driving' were excluded): factor loadings 
after promax rotation
Subscale Factor 1 Factor 2
Near vision 0.909 -0.118
Mental health 0.866 0.052
Role limitation 0.850 -0.043
Dependency 0.838 0.053
Distance vision 0.828 0.067
General vision 0.757 -0.095
Social functioning 0.724 0.072
Peripheral vision -0.033 0.701
Ocular pain -0.094 0.575
Color vision 0.243 0.421Health and Quality of Life Outcomes 2005, 3:65 http://www.hqlo.com/content/3/1/65
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while the 'Ocular Pain', 'Peripheral Vision', and 'Color
Vision' subscales correlated strongly with the second fac-
tor. Therefore, if only one composite score is to be com-
puted, that score should not include the 'Ocular Pain',
'Peripheral Vision', or 'Color Vision' subscales. Nonethe-
less, for studies of interventions involving small numbers
of subjects we suggest using the 7-subscale composite
score, given the caveat that it would not reflect problems
with color vision, peripheral vision, or ocular pain. Fur-
thermore, we suggest using the 10-subscale composite
score when evaluating patients who have ocular pain or a
disorder involving color vision.
Few reports [4,25] were available up until now on the
responsiveness of the NEI VFQ-25. Almost no changes
were observed in the VFQ-25 scores over 2 months in the
reference group. In contrast, in the patients who under-
went cataract surgery, many subscale scores increased by
about 20 points. These increases occurred not only in the
scores on subscales related directly to vision ('General
Vision', 'Near Vision', and 'Distance Vision'), but also in
the scores on subscales that are less vision-specific ('Men-
tal Health', 'Dependency', 'Social Functioning', and 'Role
Limitation'). Scores on the 'General Health', 'Color
Vision', and 'Peripheral Vision' subscales did not change
with cataract surgery. These results show that with the Jap-
anese version of the NEI VFQ-25, one can easily detect
clinically important changes such as those resulting from
cataract surgery.
Interpretation of these results is limited in at least four
ways. First, this study did not include patients with dia-
betic retinopathy, low vision, and a large number of other
eye conditions. Thus, whether these findings are applica-
ble to patients with diseases other than cataracts, glau-
coma, and ARMD remains to be studied. Second, we used
a convenience sample of persons with these conditions,
and they may not represent the full clinical spectrum of
each disease. Third, it is unclear whether the mode of
administration (self-administered or interviewer adminis-
tered) would have important effects on the results. How-
ever, we obtained the present data with trained
interviewers, and we note that the findings are similar to
those obtained in a field survey with the original English
version, even though the questionnaire in that survey was
self-administered. Fourth, the responsiveness results were
obtained without the aforementioned substitutions in the
'Near Vision' and 'Distance Vision' subscales. Thus, the
responsiveness of those two subscales should be exam-
ined again, after the recommended substitutions.
Adjusted change in NEI VFQ-25 scores in the cataract-surgery group and the reference group Figure 1
Adjusted change in NEI VFQ-25 scores in the cataract-surgery group and the reference group. Change score 
adjusted for sex and age.
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Conclusion
In conclusion, psychometric testing indicates that data
obtained with the Japanese version of the NEI VFQ-25 are
sufficiently reliable, valid, and responsive for group-level
comparisons. For reasons described in detail above, we
suggest that a few items be substituted and that a few be
removed from the composite score. Using this scale in
vision-related clinical research in Japan should facilitate
evaluations of clinical care and outcomes from the stand-
point of the patient.
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